Method and apparatus for independent atrial and ventricular defibrillation

• US 5,641,326 A
• Filed: 12/13/1993
• Issued: 06/24/1997
• Est. Priority Date: 12/13/1993
• Status: Expired due to Fees

• Current Assignee: Angeion Corporation (Niterra Co., Ltd.)
• Original Assignee: Angeion Corporation (Niterra Co., Ltd.)
• Inventors: Adams, Theodore P.
• Primary Examiner(s): Kamm, William E.
• Assistant Examiner(s): SCHAETZLE, KENNEDY
• Application Number:
  US08/166,219
• Time in Patent Office: 1,289 Days
• Field of Search: 607/5, 607/123, 607/122, 607/119
• US Class Current: 607/5
• CPC Class Codes: A61N 1/05 for implantation or insertion into the body, e.g. heart electrode A61N1/06 takes precedence
• CPC Class Codes: A61N 1/056 Transvascular endocardial electrode systems
• CPC Class Codes: A61N 1/3918 characterised by shock pathway, e.g. by electrode configuration

Abstract

The invention discloses a catheter for use with an implantable cardioverter in which the catheter has at least two discharge electrodes positioned along the length of the catheter in such a fashion as to place each electrode in the optimal position to effect atrial and ventricular cardioversion and defibrillation.

Claims

1. An improved implantable system for producing a countershock for electrically cardioverting a human patient'"'"'s heart, the implantable system being a self-contained human implantable device including a charge storage means, and means for selectively discharging the electrical charge in the charge storage means as a countershock to be delivered through electrodes implanted in the human patient in response to a sensing of a myocardial arrhythmia in the human patient, the improvement comprising:

a) discharge electrode means electrically connected to the charge storage means for electrically cardioverting the human patient'"'"'s heart upon a discharge of said charge storage means, the discharge electrode means including at least one implanted intravascular catheter carrying a first and second discharge electrodes axially spaced apart on the catheter by no more than 5 cm to effect appropriate anatomic positions of the first and second electrodes within the atrium and the ventricle respectively of the human patient'"'"'s heart; and

b) control means as part of the means for selectively discharging for controlling a polarity of the discharge of the charge storage means to ensure that the first and second discharge electrodes are not simultaneously discharged in an opposite polarity at any time during the discharge of the charge storage means.

2. The system of claim 1 in which the discharge electrode means comprises a subcutaneous patch electrode and an intravascular catheter bearing two or more discharge electrodes of which one catheter borne electrode is placed substantially within the right atrium so that the subcutaneous patch electrode and the right atrial discharge electrode are capable of independently electrically cardioverting the human patient'"'"'s heart suffering from atrial dysrhythmia.

3. The system of claim 1 in which the discharge electrode means comprises a pulse generator housing subcutaneous electrode and an intravascular catheter bearing two or more discharge electrodes of which one catheter borne electrode is placed substantially within the right atrium so that the pulse generator housing subcutaneous electrode and the right atrial discharge electrode are capable of independently electrically cardioverting the human patient'"'"'s heart suffering from atrial dysrhythmia.

4. The system of claim 1 in which the control means comprises means for controlling the discharge phase, duration, and direction.

5. A method for operating an implantable device for electrically cardioverting a human heart to treat myocardial dysrhythmia, the method comprising the steps of:

a) implanting an intravascular catheter within the human heart carrying at least two discharge electrodes axially spaced apart less than 5 cm from one another;

b) implanting proximate the human heart one or more additional discharge electrodes;

c) implanting a cardioverting system;

d) electrically connecting the intravascular catheter and the one or more additional discharge electrodes to the implanted cardioverting system;

e) using the cardioverting system to perform the device-implemented steps of;

e2) sensing for myocardial dysrhythmia amenable to electrical cardioverting by the cardioverting system;

e2) discharging the cardioverting system in response to sensing a myocardial dysrhythmia; and

e3) controlling a polarity of an electrical discharge of the cardioverting system to prevent the at least two electrodes of the intravascular catheter from simultaneously having opposite polarity at any time during the electrical discharge.

6. The method of claim 6 in which the controlling step comprises controlling the discharge phase, duration, and direction.

7. An improved implantable intravascular catheter having at least two electrical discharge electrodes spaced for appropriate anatomic positioning within a human heart for independent atrial and ventricular defibrillation, the improved catheter comprising:

a proximal first discharge electrode located on the catheter, positionable within the right atrium of the human heart, and capable of delivering an electrical countershock of greater than about 1.0 Joules; and

a distal second discharge electrode located on the catheter, positionable within the right ventricle of the human heart, and capable of delivering an electrical countershock of greater than about 1.0 Joules, the distal second discharge electrode being optimally spaced apart from the proximal first discharge electrode by no more than 5 cm.